Benzinga | Aug 13, 2020 04:12PM EDT

Navidea Biopharmaceutical Q2 EPS $(0.11) Up From $(0.24) YoY, Sales $271.00K Beat $156.00K Estimate

Navidea Biopharmaceutical (AMEX:NAVB) reported quarterly losses of $(0.11) per share. This is a 54.17 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $271.00 thousand which beat the analyst consensus estimate of $156.00 thousand by 73.72 percent. This is a 4.19 percent increase over sales of $260.09 thousand the same period last year.